The Twinning European Commission funded-project ๐ง๐ช๐๐ก2๐ฃ๐๐ฃ๐ฆ๐ – ๐๐ธ๐ช๐ฏ๐ฏ๐ช๐ฏ๐จ ๐ง๐ฐ๐ณ ๐ฆ๐น๐ค๐ฆ๐ญ๐ญ๐ฆ๐ฏ๐ค๐ฆ ๐ช๐ฏ ๐ฃ๐ช๐ฐ๐ฑ๐ฉ๐บ๐ด๐ช๐ค๐ด ๐ฐ๐ง ๐ฑ๐ณ๐ฐ๐ต๐ฆ๐ช๐ฏ ๐ช๐ฏ๐ต๐ฆ๐ณ๐ข๐ค๐ต๐ช๐ฐ๐ฏ๐ด ๐ข๐ฏ๐ฅ ๐ด๐ฆ๐ญ๐ง-๐ข๐ด๐ด๐ฆ๐ฎ๐ฃ๐ญ๐บ consortium will meet between 1 and 3 February at Ciรชncias ULisboa.
In this kick-off meeting, researchers will be able to discuss and set-up in detail the strategy and activities that will be promoted within the project, which aims at organizing staff exchanges, advanced training schools, conferences and workshops between academia in the field of proteins and protein folding.ย
Clรกudio Gomes, PI at Protein Misfolding and Amyloids in Biomedicine Lab – BioISI – Ciรชncias ULisboa,ย is the project coordinator. The projects counts with several other BioISI researchersย (Bรกrbara Henriques, Miguel Machuqueiro, Paulo Costa, Bruno L. Victor,ย Ana Nunes, Patrรญcia Faรญsca, Mรกrio Rodrigues, Ana Carapeto and Federico Herrera) and with Romana Santos, researcher at the Marine and Environmental Sciences Centre – Ciรชncias ULisboa. The consortium also integrates several European scientists (from the University of Copenhagen, Tel Aviv University and University of Cambridge) who, together with BioISI researchers, are eager to take the state-of-the-art research in Biochemistry and Biophysics of Proteins, with impact in biomedicine and biotechnology, one step further.
Alongside the kick-off meeting, a plenary conference series- given byย experts from the consortium (Michele Vendruscolo,ย University of Cambridge;ย Ehud Gazit, Tel Aviv University; and Kresten Lindorff-Larsen,ย University of Copenhagen)ย – will also be held. These conferences are open to the academic community and aim at sharing cutting-edge research within TWIN2PIPSA scientific field. Some of the topics will include the illustration of experimental and computational approaches applied to the study of the molecular aspects of protein aggregation and neurodegeneration in Alzheimer’s disease, biomedical and biotechnological applications of peptides and proteins, and the mechanisms of function loss underlying various conformational diseases.
More info about TWIN2PIPSA: